The 15 percent tariff rate agreed under the new deal could significantly impact pharma firms reliant on European imports.

The IMF raised its global growth forecast Tuesday as efforts to circumvent Donald Trump's sweeping tariffs sparked a bigger-than-expected surge in trade, while the US president stepped back from some ...

This regulatory relief, combined with several other compelling catalysts, creates a pathway for the stock to potentially ...

Novo Nordisk stock collapsed 26% in its worst trading day ever after slashing guidance on Wegovy sales and naming a new CEO.

HC Wainwright initiates Ultragenyx at Buy with $80 target, citing strong rare disease pipeline and late-stage data expected ...

Celcuity stock (NASDAQ: CELC), a clinical-stage biotechnology company, experienced an extraordinary 3x surge in a single ...

Danish pharmaceutical giant Novo Nordisk on Tuesday cut its full-year sales and profit guidance, citing weaker growth ...

We recently published These 10 Stocks are Winning Big. Esperion Therapeutics, Inc. (NASDAQ:ESPR) is one of the ...

If you're looking for high-yield stocks in the healthcare sector, it's hard to beat this trio of industry giants offering ...

Google's CEO thinks cellphones will be at the center of consumer experiences for "the next two to three years at least." ...

European stock markets are heading for a higher open today, according to IG data, with major bourses heading for gains of ...

Pfizer Inc. (NYSE:PFE) is one of the stocks that Jim Cramer weighed in on. A caller asked if they should continue to hold the ...